Netherlands· NL-e8837f242453

Abirateron Mylan 500 mg, filmomhulde tablet

A abiraterone product containing abirateronacetaat, registered in Netherlands by Mylan Pharmaceuticals Limited. The same ATC class is registered in 18 of our 19 countries.

ATC L02BX03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about abirateronacetaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Abiraterone is registered in 18 of 19 countries.

Countries holding a registration under ATC L02BX03 (abiraterone), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search abiraterone products by name

Abiraterone · ATC L02BX03

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of abiraterone costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Abiraterone · price per daily dose (1 g)

USD · FX 28 Sept 2026

CH Switzerland$42.72
FR France$33.07

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ABIRATERONACETAAT
Manufacturer: Mylan Pharmaceuticals Limited
Country: Netherlands (NL)
ATC code: L02BX03
ATC class: Abiraterone
Defined daily dose: 1 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/21/1571

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for abiraterone.

Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check abiraterone against other medicines How interaction checks work

Abiraterone · interactions on record

461 records

101 severe
335 moderate
25 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
LoperamideA07DA03severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Abiraterone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All abiraterone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Abiral, Abirateron +pharma
Belgium · Abirateron Eg, Abirateronacetaat Eg (Eurogenerics) Nv
Bulgaria · Абиратерон Msn, Абиратерон Деватис
Cyprus · Abiraterone Farmoz, Abiraterone Pharmazac
Czechia · Abirateron Ashcure, Abirateron Pharmagen
Germany · Abibam®, Abiranio
Denmark · Abirateron "olpha", Abirateron "sandoz"
Estonia · Abiraterone G.L. Pharma, Abiraterone Norameda
Spain · Abiraterona Ashcure, Abiraterona Cipla
Finland · Abirateron Avansor, Abirateron Devatis
France · Abiraterone Acetate Zydus, Abiraterone Arrow
United Kingdom (Northern Ireland) · Abiraterone, Abiraterone Abdi
Greece · Abinone, Abiprostem
Croatia · Abirateron Alpha-Medical, Abirateron Devatis
Hungary · Abaxan, Abirateron Galenika
Ireland · Abiraterone, Abiraterone Aristo
Iceland · Abirateron, Abirateron Medical Valley
Italy · Abiraterone Abdi, Abiraterone Abdi Farma
Liechtenstein · Abiraterone Accord, Abiraterone Mylan
Lithuania · Abiraterone G.L. Pharma, Abiraterone Norameda
Luxembourg · Abirateron Eg, Abiraterone Eugia
Latvia · Abiraterone G.L. Pharma, Abiraterone Norameda
Malta · Abiraterone Ashcure, Abiraterone Clonmel
Norway · Abirateron Devatis, Abirateron Medical Valley
Poland · Abiral, Abirateron Sun
Portugal · Abiraterona Bluepharma, Abiraterona Eugia
Romania · Abirateron? Lannacher, Abirateronă
Sweden · Abirateron Devatis, Abirateron Medical Valley
Slovenia · Abirateron Galenika, Abirateron Teva
Slovakia · Abirateron Msn, Abirateron Pharmagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d00a600d-018a-4e4b-8f35-01a102185ada
GET /v1/drugs/d00a600d-018a-4e4b-8f35-01a102185ada?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/abiraterone-mylan-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Abiraterone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp126461",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "POLYVINYLALCOHOL (E 1203)",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ABIRATERONACETAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2021/08/20",
  "procedure_number": "EMEA/H/C/005368",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/21/1571",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about abiraterone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console